Ticker: ARMP

Armata Pharmaceuticals, Inc. (NYSE: ARMP) Quick read: Armata is a clinical‑stage phage therapeutics company showing positive clinical readouts (AP‑SA02 and AP‑PA02) while aggressively cutting operating spend. At the same time the company faces acute liquidity strain, heavy debt with expensive rel...